RXSIGHT INC. - COMMON STOCK

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

07 Jan 2024 10:00:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

27 Dec 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Third Quarter 2023 Financial Results

09 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Educational and Product Announcements for AAO 2023

02 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023 

26 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

23 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Second Quarter 2023 Financial Results

07 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023

25 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports First Quarter 2023 Financial Results

09 May 2023 16:05:02 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the Bank of America Healthcare Conference

26 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023

25 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

24 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the Needham Healthcare Conference

05 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

06 Mar 2023 16:05:01 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the Oppenheimer Healthcare Conference

28 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023

21 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock

14 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

08 Feb 2023 00:45:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Proposed Public Offering of Common Stock

07 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results

08 Jan 2023 16:00:00 By Nasdaq GlobeNewswire